Rosaura Gutiérrez-Vargas1, María Luisa Díaz-García2, Miguel Ángel Villasís-Keever3, Javier Portilla-Robertson4, Marta Zapata-Tárres5. 1. Programa de Maestría y Doctorado en Medicina, Odontología y Ciencias de la Salud, Universidad Nacional Autónoma de México, Mexico City, Mexico. 2. Departamento de Metodología, Instituto Nacional de Pediatría, Mexico City, Mexico. 3. Unidad de Investigación en Epidemiología Clínica, Hospital de Pediatría, Centro Médico Nacional S. XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico. 4. Coordinación de Patología Oral, División de Estudios de Posgrado, Facultad de Odontología, Universidad Nacional Autónoma de México, Mexico City, Mexico. 5. Departamento de Oncología Médica, Instituto Nacional de Pediatría, Mexico City, Mexico. Electronic address: mzapatatarres@gmail.com.
Abstract
BACKGROUND: Oral mucositis (OM) is an inflammatory reaction of the oropharyngeal mucosa to cumulative chemotherapy (CT) and radiation therapy (RT), affecting one or more parts of the digestive tract along with the quality of life (QoL) of the patient. The goal of this study was to identify valid and reliable tools to evaluate QoL related to OM. METHODS: A systematic review of the literature was conducted up to May 2016. Articles were selected by peers using the PubMed database through a search following the inclusion and exclusion criteria and STAndards for the Reporting of Diagnostic accuracy studies (STARD) checklist with a cut-off point ≥ 70%. RESULTS: We identified four relevant articles that described instruments to assess the QoL related to OM in patients undergoing cancer treatment. CONCLUSIONS: The evaluation of the QoL in patients with OM is a difficult scenario because of its multiple variables. The knowledge of this relationship is limited because general instruments of oral health or cancer therapy are commonly used for evaluation. However, valid instruments are already available for estimating the impact of OM on the QoL from the patient's perspective.
BACKGROUND:Oral mucositis (OM) is an inflammatory reaction of the oropharyngeal mucosa to cumulative chemotherapy (CT) and radiation therapy (RT), affecting one or more parts of the digestive tract along with the quality of life (QoL) of the patient. The goal of this study was to identify valid and reliable tools to evaluate QoL related to OM. METHODS: A systematic review of the literature was conducted up to May 2016. Articles were selected by peers using the PubMed database through a search following the inclusion and exclusion criteria and STAndards for the Reporting of Diagnostic accuracy studies (STARD) checklist with a cut-off point ≥ 70%. RESULTS: We identified four relevant articles that described instruments to assess the QoL related to OM in patients undergoing cancer treatment. CONCLUSIONS: The evaluation of the QoL in patients with OM is a difficult scenario because of its multiple variables. The knowledge of this relationship is limited because general instruments of oral health or cancer therapy are commonly used for evaluation. However, valid instruments are already available for estimating the impact of OM on the QoL from the patient's perspective.
Authors: Sezin Yuce Sari; Caglayan Selenge Beduk Esen; Gozde Yazici; Deniz Yuce; Mustafa Cengiz; Gokhan Ozyigit Journal: Support Care Cancer Date: 2021-07-20 Impact factor: 3.603